Schistosomiasis is the most common of the trematode infections, affecting more than 200 million people worldwide.1,2 Hepatosplenic schistosomiasis occurs primarily with infection due to Schistosoma mansoni and less often with Schistosoma japonicum. If left untreated patients may ultimately develop massive hepatosplenomegaly, portal hypertension, and variceal hemorrhage.1–3 The diagnosis of hepa...

Acute myelopathy is increasingly being recognized as a common neurological complication of schistosomiasis. Schistosome eggs reach the spinal cord either as egg emboli or as eggs produced by ectopic worms. This leads to inflammatory reaction and granuloma formation around the eggs. Patients with spinal schistosomiasis may not have clinical evidence of schistosomiasis. The typical clinical pictu...

The aim of this study was to assess the prevalence of schistosomiasis mansoni in Maranhão State, Brazil, from 1997 to 2003, based on data from the regional health offices included in the Schistosomiasis Control Program. The statistical method was polynomial regression. The municipalities (counties) of Bacabal and São Luís showed a constantly downward trend throughout the time series. Colinas sh...

Hepatosplenic schistosomiasis refers to the major complication of chronic infection with Schistosoma mansoni, S japonicum and S mekongi, schistosomal portal hypertension. Hepatosplenic schistosomiasis is usually, but not invariably, associated with enlargement of the liver and spleen, and reversible hepatosplenomegaly may occur in early infections not complicated by the development of portal hy...

BACKGROUND The Chinese government lists advanced schistosomiasis as a leading healthcare priority due to its serious health and economic impacts, yet it has not been included in the estimates of schistosomiasis burden in the Global Burden of Disease (GBD) study. Therefore, the quality of life and disability weight (DW) for the advanced cases of schistosomiasis japonica have to be taken into acc...

BACKGROUND Schistosomiasis remains a global health problem with an estimated 250 million people in 78 countries infected, of whom 85% live in Sub-Saharan Africa. Preventive chemotherapy remains the key public health strategy to combat schistosomiasis worldwide. Recently the WHO emphasized on the use of integrative approaches in the control and elimination of schistosomiasis. However, a detailed...

BACKGROUND Renal tract involvement is implicated in both early and late schistosomiasis leading to increased disease burden. Despite there being good estimates of disease burden due to renal tract disease secondary to schistosomiasis at the global level, it is often difficult to translate these estimates into local communities. The aim of this study was to assess the burden of urinary tract pat...

BACKGROUND Human schistosomiasis is a highly prevalent neglected tropical disease (NTD) caused by Schistosoma species. Research on the molecular mechanisms influencing the outcomes of bladder infection by Schistosoma haematobium is urgently needed to develop new diagnostics, therapeutics and infection prevention strategies. The objective of the research study was to determine the microbiome fea...

Objective: Knowledge, attitudes and preventative practices of risk groups for neglected tropical diseases such as intestinal schistosomiasis are important aspects for their control. This study aimed to determine the prevalence of Schistosoma mansoni, knowledge, perceptions and preventative practices of school children towards schistosomiasis in the Sengerema district, Tanzania. Methods: We cond...

Schistosomiasis is a parasitic disease caused by blood flukes (Trematodes) of the genus Schistosoma (S.). It is well documented that schistosomiasis haematobium was endemic in Ancient Egypt. Infection was diagnosed in mummies 3000, 4000 and 5000 years old. Scott was the first to describe the pattern of schistosomiasis infection in Egypt. Schistosomiasis haematobium was highly prevalent (60%) bo...